Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | SCN1A | P35498 | 1/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.55 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225647 | 0.84 | TSHR (0.57) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL9126255 | 0.83 | L3MBTL1 (0.72) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL13652653 | 0.81 | HSD17B10 (0.67) | TSHRSMN1; SMN2HSD17B10ALDH1A1MAPT | |
| SCHEMBL4279652 | 0.80 | SMN1; SMN2 (0.57) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL19841939 | 0.79 | SMN1; SMN2 (0.58) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL8634488 | 0.79 | HTT (0.54) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL13333916 | 0.79 | MAPT (0.57) | TSHRSMN1; SMN2HSD17B10ALDH1A1EPHX2 | |
| SCHEMBL6796256 | 0.78 | ALDH1A1 (0.78) | TSHRSMN1; SMN2HSD17B10ALDH1A1MAPT | |
| SCHEMBL1689206 | 0.78 | EPHX2 (0.68) | TSHRSMN1; SMN2EPHX2MAPTGAA | |
| SCHEMBL19255208 | 0.78 | MAPT (0.59) | TSHRHSD17B10EPHX2MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117618346-A | Ioethalamine suspension, preparation method thereof, ioethalamine suspension, preparation method thereof and application thereof | 四川德合制药有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2021054927-A2 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-03-25 | — | — | WO | claimed |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-02-13 | — | — | US | claimed |
| CN-109647506-A | A kind of load type gold catalyst preparation method and purposes | 华东理工大学 | 2019-04-19 | — | — | CN | claimed |
| US-9622969-B2 | Polymer conjugated protein micelles | SOUTH DAKOTA STATE UNIV (US) | 2017-04-18 | — | — | US | claimed |
| US-20140370110-A1 | POLYMER CONJUGATED PROTEIN MICELLES | SOUTH DAKOTA STATE UNIVERSITY (US) | 2014-12-18 | — | — | US | claimed |
| EP-0819739-B1 | Hot-melt ink composition | BROTHER IND LTD (JP) | 2001-10-24 | — | — | EP | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1089705-A1 | STICK-SHAPED COSMETIC COMPOSITIONS | Cognis Deutschland GmbH (DE) | 2001-04-11 | — | — | EP | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1999066895-A1 | STICK-SHAPED COSMETIC COMPOSITIONS | COGNIS DEUTSCHLAND GMBH (DE) | 1999-12-29 | — | — | WO | claimed |
| EP-0676454-B1 | Hot melt ink utilizable for ink jet printer | BROTHER IND LTD (JP) | 1999-10-27 | — | — | EP | claimed |
| EP-0181198-B1 | HOT MELT IMPULSE INK JET INK | DATAPRODUCTS CORPORATION (US) | 1992-04-15 | — | — | EP | claimed |
| EP-3442354-B1 | FORMULATION AND PRODUCTION OF SPINACH EXTRACT WITH BETA ECDYSON | DR GOETZ GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-12594257-B2 | Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers | ARDAN PHARMA S.A.S. (AR) | 2026-04-07 | — | — | US | disclosed |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | BASF SE (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-0002243-B1 | SOLID COMPOSITIONS BASED ON PHOSPHITES STABILISED AGAINST HYDROLYSIS FOR STABILISING POLYOLEFINS | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-02 | — | — | EP | disclosed |
| EP-0037375-A1 | Insecticidal-vapours emitting device | Airwick AG (CH) | 1981-10-07 | — | — | EP | disclosed |
| EP-0036385-A2 | Insecticidal vapour-emitting compositions on the basis of pyrethrinoids | Airwick AG (CH) | 1981-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | GSTK1, GSTO1, GSTM2 | TSHR 3941/4885SMN1; SMN2 4125/4885HSD17B10 492/4885 |
| US-20140370110-A1 | POLYMER CONJUGATED PROTEIN MICELLES | MTDH, PSMG3, GHITM | TSHR 3161/4885SMN1; SMN2 1968/4885HSD17B10 3318/4885 |
| US-12594257-B2 | Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers | TMEM94, TMEM126A, TMEM41B | TSHR 2430/4885SMN1; SMN2 3859/4885HSD17B10 4083/4885 |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | RAD50, CTSA, MCM7 | TSHR 853/4885SMN1; SMN2 2573/4885HSD17B10 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.